Ticker · CUSIP 221015100

CRVS

CORVUS PHARMACEUTICALS INC
Healthcare·Biotechnology
···Share
Holders (tracked)
9
Combined shares
4,598,053
Combined value
$35.41M
Last close
$16.74
Quarter
2025Q4
Price · 1Y$16.74+13.50 (+416.67%)H $25.52 · L $3.20 · Avg Vol 1.6M
Position opened
$5.00$10.00$15.00$20.00$25.00VolJul 25Oct 25Jan 26Apr 26
Tracked holders · last 8 quarters
+1 vs previous quarter over the last 8.
962024Q12025Q4
Price is +117.4% vs the avg quarter-end implied price across tracked holders.

SEC event timeline

13 events
  1. Ken Griffin (Citadel Advisors) added2026-02-17
    +165,416 shares · 2025Q4
    Position
  2. D.E. Shaw & Co. added2026-02-17
    +39,340 shares · 2025Q4
    Position
  3. Two Sigma Investments trimmed2026-02-17
    −59,762 shares · 2025Q4
    Position
  4. Izzy Englander (Millennium Mgmt) opened position2026-02-17
    +688,770 shares · 2025Q4
    Position
  5. Steve Cohen (Point72) trimmed2026-02-17
    −3,579,274 shares · 2025Q4
    Position
  6. T. Rowe Price added2026-02-17
    +1,696 shares · 2025Q4
    Position
  7. Wellington Management added2026-02-17
    +134,508 shares · 2025Q4
    Position
  8. Steve Cohen (Point72) trimmed2025-11-14
    −588,099 shares · 2025Q3
    Position
  9. Two Sigma Investments trimmed2025-11-14
    −20,553 shares · 2025Q3
    Position
  10. D.E. Shaw & Co. opened position2025-11-14
    +25,575 shares · 2025Q3
    Position
  11. T. Rowe Price added2025-11-14
    +6,110 shares · 2025Q3
    Position
  12. Wellington Management added2025-11-14
    +77,828 shares · 2025Q3
    Position
  13. Renaissance Technologies exited2025-11-13
    −165,188 shares · 2025Q3
    Position

Insider activity

No insider transactions in the last 30 days.
View full insider history for CRVS →
Follow-the-investor returns
If you'd copied each holder of CRVS…
Cost basis inferred from each manager's quarter-over-quarter position changes. Sorted by % return on the position they're still holding.
InvestorFirst inCost basisReturnPosition value today
Two Sigma Investments2018Q4$3.19+425.6%$2.4M
Steve Cohen (Point72)2017Q1$3.45+385.7%$48.1M
Wellington Management2025Q1$6.15+172.3%$5.3M
Izzy Englander (Millennium Mgmt)2016Q1$6.84+144.9%$11.5M
Ken Griffin (Citadel Advisors)2020Q1$7.47+124.0%$3.5M
Ken Griffin (Citadel Advisors)2020Q1$7.47+124.0%$3.5M
Ken Griffin (Citadel Advisors)2020Q1$7.47+124.0%$3.5M
D.E. Shaw & Co.2025Q3$7.57+121.1%$1.1M
T. Rowe Price2016Q1$11.08+51.1%$571K

Who moved on this name in 2025Q4

Position changes reported for the latest quarter, grouped by direction.
New positions1
Added to4
Trimmed2
Exited0
—

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2022Q1
8
$9.6M
2022Q2
6
$4.5M
2022Q3
5
$3.4M
2022Q4
7
$2.8M
2023Q1
4
$2.9M
2023Q2
5
$3.1M
2023Q3
7
$2.0M
2023Q4
7
$2.4M
2024Q1
6
$2.3M
2024Q2
8
$13.5M
2024Q3
8
$35.2M
2024Q4
8
$22.3M
2025Q1
10
$17.5M
2025Q2
8
$31.2M
2025Q3
8
$52.0M
2025Q4
9
$35.4M

Who owns CRVS

9 super-investors · 2025Q4
Tracked stake
4.60M
shares
Combined value
$35M
% of shares outstanding
—
shares-out unknown
Quarter action mix
New1Added6Trim2
#ManagerSharesValue
1Steve Cohen
Point72
2.88M$22M
2Izzy Englander
Millennium Mgmt
688.8K$5M
3Wellington Management314.7K$2M
4Ken Griffin
Citadel Advisors
208.2K$2M
5Ken Griffin
Citadel Advisors
175.0K$1M
6Two Sigma Investments143.6K$1M
7Ken Griffin
Citadel Advisors
93.8K$722K
8D.E. Shaw & Co.64.9K$500K
9T. Rowe Price34.1K$263K

Recent moves

20 transactions
Embed this chart
Paste this iframe anywhere to embed the live CRVS chart.
<iframe src="https://openstocks.me/embed/stocks/CRVS" width="100%" height="480" frameborder="0" loading="lazy" title="CRVS chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>
Preview: https://openstocks.me/embed/stocks/CRVS
Explore related topics